CME Group Inc. $CME Shares Purchased by PFG Investments LLC

PFG Investments LLC lifted its stake in CME Group Inc. (NASDAQ:CME) by 8.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,514 shares of the financial services provider’s stock after purchasing an additional 267 shares during the quarter. PFG Investments LLC’s holdings in CME Group were worth $968,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the stock. Webster Bank N. A. increased its stake in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares in the last quarter. Highline Wealth Partners LLC grew its holdings in shares of CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the last quarter. Wayfinding Financial LLC acquired a new position in shares of CME Group in the 1st quarter valued at $25,000. Cornerstone Planning Group LLC raised its stake in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 55 shares during the last quarter. Finally, Golden State Wealth Management LLC lifted its position in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 98 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on CME shares. Morgan Stanley increased their price objective on CME Group from $303.00 to $312.00 and gave the company an “overweight” rating in a report on Wednesday. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 13th. Barclays set a $298.00 price objective on shares of CME Group and gave the company an “equal weight” rating in a research note on Thursday, July 24th. Piper Sandler increased their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 15th. Finally, UBS Group reduced their target price on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a report on Monday, September 8th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $274.15.

CME Group Price Performance

NASDAQ:CME opened at $265.43 on Friday. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. The company has a 50 day moving average price of $270.28 and a 200-day moving average price of $271.11. CME Group Inc. has a 1-year low of $213.94 and a 1-year high of $290.79. The firm has a market cap of $95.66 billion, a price-to-earnings ratio of 25.70, a price-to-earnings-growth ratio of 4.83 and a beta of 0.41.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating the consensus estimate of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the business earned $2.56 earnings per share. The firm’s revenue was up 10.4% on a year-over-year basis. Equities research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s payout ratio is currently 48.40%.

Insiders Place Their Bets

In other news, insider Timothy Francis Mccourt sold 379 shares of the stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director William R. Shepard purchased 262 shares of the business’s stock in a transaction that occurred on Thursday, September 25th. The stock was bought at an average cost of $265.19 per share, with a total value of $69,479.78. Following the acquisition, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their position. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 13,043 shares of company stock worth $3,527,956. Company insiders own 0.30% of the company’s stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.